Antidepressant Makers Under Fire For Hiding Data

Law360, New York (January 17, 2008, 12:00 AM EST) -- A new study has found that the makers of a dozen popular antidepressants selectively published the results of trials they conducted to win government approval, leading to unrealistic estimates of the drugs' effectiveness by doctors and consumers.

The study, published in this week's New England Journal of Medicine, compared drug efficacy inferred from publicly reported clinical trials with drug efficacy according to reviews by the U.S. Food and Drug Administration to determine how accurately the published literature conveys data on drug efficacy to the medical community....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.